Treatment with a BTK inhibitor has been shown to yield good depth and duration of response in patients with chronic lymphocytic leukemia, regardless of TP53 status. READ MORE
Which first-line treatment strategy was shown to be safe and effective in older patients with newly diagnosed Ph-negative ALL?
According to a recent research letter, the risk for breast cancer morbidity differs by subtype in survivors of Hodgkin lymphoma treated with radiotherapy.
A potential new first-line therapeutic option may have been identified for older patients with a common blood cancer type.
A recent study examined whether a history of Epstein-Barr virus positivity or immunosuppression affects outcomes in patients with a type of B-cell lymphoma.